Subscribe To
Sagimet biosciences to present at the h.c. wainwright 7th annual nash investor conference
SAN MATEO, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing no...
October 18, 2023, 4:05 pm
Akoya biosciences announces peer-reviewed publication using ultrahigh-plex spatial phenotyping of head and neck cancer to identify distinct immune and metabolic signatures
MARLBOROUGH, Mass., Oct. 17, 2023 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today anno...
October 17, 2023, 2:22 pm
Neurobo to present at the h.c. wainwright 7th annual nash investor conference
BOSTON , Oct. 17, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform ca...
October 17, 2023, 8:01 am
89bio to participate in the h.c. wainwright 7ᵗʰ annual nash investor conference
SAN FRANCISCO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...
October 17, 2023, 8:00 am
Poolbeg pharma up 8% on deal with nasdaq biotech
Shares in Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) rose 8% in early trading after the company announced a partnership with an unnamed Nasdaq-listed ...
October 17, 2023, 4:03 am
Poolbeg pharma inks collaboration agreement with nasdaq biotech
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) said it has inked an agreement with an unnamed Nasdaq-listed biopharmaceutical entity aimed at developing ...
October 17, 2023, 2:57 am
Relmada therapeutics to present new preclinical data on its psilocybin program at aasld the liver meeting® 2023
Low-dose psilocybin generated s tatistically significant reduc tions in liver fat content, plasma glucose levels and body weight gain in a mice model ...
October 11, 2023, 8:31 am
Why shares of 89bio plummeted on tuesday
89bio is a clinical-stage biotech company. It focuses on treatments for liver and cardiometabolic disea...
October 10, 2023, 4:13 pm
$vktx: consolidation in viking therapeutics provides an opportunity
Viking Therapeutics Inc. is an innovative biotechnology company developing novel therapeutics for metabolic...
October 2, 2023, 6:17 pm
Natural astaxanthin market to generate demand to a valuation of usd 248.3 million by 2032 || market.us
Natural astaxanthin is recognized as a natural and organic product with notable benefits for various aspects of health. Research has shown its profoun...
September 28, 2023, 11:12 am
Sagimet biosciences announces completion of enrollment of 120 patients for phase 3 clinical trial by its partner ascletis of denifanstat combined with bevacizumab for treatment of recurrent glioblasto
SAN MATEO, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing ...
September 27, 2023, 8:05 pm
Sagimet biosciences announces completion of enrollment of 120 patients for phase 3 clinical trial by its partner ascletis of denifanstat combined with bevacizumab for treatment of recurrent glioblasto
SAN MATEO, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing ...
September 27, 2023, 8:05 pm
Why shares of soleno therapeutics are booming on tuesday
Soleno specializes in treating rare metabolic disorders. The company's lead therapy, DCCR, fared well a...
September 26, 2023, 12:51 pm
Novo nordisk (nvo), valo ink deal to develop heart disease drugs
Novo Nordisk (NVO) collaborates with Valo Health to discover and develop novel treatments for cardiometabolic<...
September 26, 2023, 11:17 am
Novo nordisk and valo health to use ai to develop treatments for cardiometabolic diseases
Denmark's Novo Nordisk (NVO) struck a deal with U.S.-based health tech firm Valo Health to use artificial intelligence (AI) to discover and develop tr...
September 25, 2023, 4:35 pm
Novo nordisk announces ai collaboration with valo health for cardiometabolic treatments
Novo Nordisk (NYSE:NVO) has announced a collaboration with Valo Health to discover and develop novel treatments for cardio...
September 25, 2023, 9:51 am
Novo nordisk partners with valo health on ai drug discovery
Novo Nordisk NVO, +0.01% on Monday announced a partnership with Valo Health Inc., a technology company specializing in AI-powered drug discovery and d...
September 25, 2023, 8:28 am
Journal of cellular and molecular medicine publishes preclinical data of panavance’s gp-2250 to treat pancreatic cancer
Results showed antineoplastic activity in pancreatic tumor cell lines metabolic and transcriptional fin...
September 12, 2023, 11:07 am
Biovie presents alzheimer's study data on patient's baseline characteristics
BioVie Inc (NASDAQ:BIVI) has unveiled early data from its Phase 3 study of its investigational drug NE3107 in patients with mild to moderate Alzheimer...
September 11, 2023, 8:42 am
Axcella health stock rockets on long covid patent win
Axcella Health Inc (NASDAQ:AXLA) saw its stock rocket some 240% higher in Tuesday's early deals after the small-cap firm announced it had secured a pa...
August 29, 2023, 9:28 am